Company / Working Capital
Thermo Fisher Scientific Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$13.5B
FY2025
5-year range
$6.7B / $13.5B
FY2021-FY2025
Trend
+53.5%
vs FY2024
Sector context
#3 of 160
Health Care
What the data says
Among 160 Health Care companies, Thermo Fisher Scientific is in the top 2% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $2.2B in FY2016 to $13.5B in FY2025.
Based on SEC 10-K filings.
$13.5B in FY2025 with a 5-year CAGR of +3.0%. Ranks 3rd among 160 companies in Health Care.
Improved from $10.6B to $13.5B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +18.0%
- 5-Year CAGR
- +3.0%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 160This company $13.5B Sector average $757.1M
▼
+1685.6% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.0%, indicating consistent growth.
- In FY2025, working capital increased 53.5% year-over-year.
- Ranks #3 out of 160 companies in the Health Care sector.
- Lowest working capital in the period was in FY2016.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.5B | +53.5% |
| FY2024 | $8.8B | -16.8% |
| FY2023 | $10.6B | +28.7% |
| FY2022 | $8.2B | +23.1% |
| FY2021 | $6.7B | -42.7% |
| FY2020 | $11.7B | +104.6% |
| FY2019 | $5.7B | +27.2% |
| FY2018 | $4.5B | +88.7% |
| FY2017 | $2.4B | +10.1% |
| FY2016 | $2.2B | +35.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026